about
Role of supportive care for terminal stage hepatocellular carcinomaAntitumor activity and mechanisms of action of total glycosides from aerial part of Cimicifuga dahurica targeted against hepatoma.Symptom management in hepatocellular carcinomaChemokine expression in hepatocellular carcinoma versus colorectal liver metastases.Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis.Potential involvement of leptin in carcinogenesis of hepatocellular carcinomaThe molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma.Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma.Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor.A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.Caspase-8 acts as a key upstream executor of mitochondria during justicidin A-induced apoptosis in human hepatoma cells.Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.Integration of hepatitis B virus DNA and hepatocellular carcinoma.High ATF5 expression is a favorable prognostic indicator in patients with hepatocellular carcinoma after hepatectomy.
P2860
Q26822263-60312532-A4C5-489B-A40C-F7AD44416E62Q33312872-21A5289C-F98C-4DAF-9480-120582CA5CCCQ33897458-7BF7CB2C-2E95-4355-B600-A415BECCEACEQ34017734-675BACFA-BF5D-4627-9C48-7AC845BA5A2BQ34322940-7FBC6DF4-D058-42FD-B36A-9F217870B3ABQ35882733-67BA837C-A66E-4A76-AAB7-7151A9509814Q36065676-C8D94C06-E8A8-46CC-BD97-2748F6A469F7Q36419017-E2AEDEA0-DF29-431D-8603-DE2BCA90339DQ36734983-AD548AD8-B1D5-4BB0-9852-746A0716B877Q36912160-867619EA-6C5A-4FA9-A8E4-ACA8909486B4Q38088842-0EB18E42-D2A8-45FB-91B0-E0B9E56C5FD5Q40250428-AFA441CA-000B-418D-B706-E32CFAB4991FQ40388158-BAF7EDC8-B7B1-4ABE-BE53-9F8D491841F5Q40479597-BCA46F75-1CC1-4ABC-855C-CFF330CEEFAEQ43038148-7A7255CC-52B8-42B0-8C47-AEA721AB8E1EQ45431140-1179D64E-CFC6-491A-B3A1-CBBED5321569Q53013310-5FCAB2A9-C0AE-4DA2-BC6D-A89632D83719
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatocellular carcinoma: are we making progress?
@ast
Hepatocellular carcinoma: are we making progress?
@en
type
label
Hepatocellular carcinoma: are we making progress?
@ast
Hepatocellular carcinoma: are we making progress?
@en
prefLabel
Hepatocellular carcinoma: are we making progress?
@ast
Hepatocellular carcinoma: are we making progress?
@en
P2860
P356
P1433
P1476
Hepatocellular carcinoma: are we making progress?
@en
P2093
Andrew X Zhu
P2860
P304
P356
10.1081/CNV-120018233
P577
2003-06-01T00:00:00Z